Products & Therapy · Metabolism · Semaglutide
Semaglutide
Semaglutide · GLP-1 receptor agonist
Glycemic control in type 2 diabetes and weight management in obesity, significantly reducing cardiovascular risk
0.25~2.4mg
Weekly injection
Pre-filled pen